• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善药用聚合物 Eudragit® EPO 和 Soluplus® 可印刷性的策略和机制。

Strategies and mechanisms to improve the printability of pharmaceutical polymers Eudragit® EPO and Soluplus®.

机构信息

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China.

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China.

出版信息

Int J Pharm. 2021 Apr 15;599:120410. doi: 10.1016/j.ijpharm.2021.120410. Epub 2021 Feb 25.

DOI:10.1016/j.ijpharm.2021.120410
PMID:33639229
Abstract

The poor printability of most pharmaceutical polymers greatly restricts the application of the fused deposition modeling (FDM) technique in the field of personalized pharmaceutical preparations. General strategies to improve printability and provide practical guidelines for the optimization of formulations are lacking. Moreover, the mechanism associated with the smooth printing process of modified printing materials needs to be investigated. In this study, three different strategies were used to improve the FDM printability of typical brittle polymers with poor printability. The relationship among additives, material properties, and printability was explored. The finite element method was used to simulate the radial stress-strain behavior of the filament, while computational fluid dynamics was used to simulate the axial melt flow field in the printing head. It was found that the addition of an inert filler (i.e., talc), a drug with high melting points (i.e., diclofenac sodium), and a polymer with high strength (i.e., plasticized ethylcellulose) effectively improved the printability of plasticized Eudragit® EPO and Soluplus®. In addition, regulating the mechanical properties of filaments improved printability, and it was deduced that printable filaments should have neither very low stiffness nor very low flexibility. The suitable melt viscosity or shear-thinning property of the printing material facilitated smooth extrusion without filament breakage or nozzle blockage. The results of this study also showed that simulation could assist in understanding the stress-strain behavior of filaments and the flow field of melts during FDM printing.

摘要

大多数药物聚合物的印刷适性较差,极大地限制了熔融沉积成型(FDM)技术在个性化药物制剂领域的应用。缺乏提高印刷适性和为配方优化提供实用指导的一般策略。此外,还需要研究与改性打印材料顺利打印过程相关的机制。在这项研究中,使用了三种不同的策略来提高典型脆性聚合物的 FDM 印刷适性,这些聚合物的印刷适性较差。探讨了添加剂、材料性能和印刷适性之间的关系。使用有限元法模拟了细丝的径向应力-应变行为,同时使用计算流体动力学模拟了打印头中的轴向熔体流动场。结果表明,添加惰性填料(即滑石粉)、熔点高的药物(即双氯芬酸钠)和强度高的聚合物(即增塑乙基纤维素)可有效提高增塑 Eudragit® EPO 和 Soluplus®的印刷适性。此外,调节细丝的机械性能可提高印刷适性,可以推断出可印刷细丝既不应具有非常低的刚度,也不应具有非常低的柔韧性。打印材料的合适熔体粘度或剪切变稀特性有利于顺利挤出,而不会出现细丝断裂或喷嘴堵塞。这项研究的结果还表明,模拟可以帮助理解 FDM 打印过程中细丝的应力-应变行为和熔体的流动场。

相似文献

1
Strategies and mechanisms to improve the printability of pharmaceutical polymers Eudragit® EPO and Soluplus®.改善药用聚合物 Eudragit® EPO 和 Soluplus® 可印刷性的策略和机制。
Int J Pharm. 2021 Apr 15;599:120410. doi: 10.1016/j.ijpharm.2021.120410. Epub 2021 Feb 25.
2
An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.一项关于使用聚合物共混物来改善通过熔融沉积建模(FDM)3D打印制备的药物固体分散体的可印刷性并调节其药物释放的研究。
Eur J Pharm Biopharm. 2016 Nov;108:111-125. doi: 10.1016/j.ejpb.2016.08.016. Epub 2016 Sep 2.
3
Development of a quantitative method to evaluate the printability of filaments for fused deposition modeling 3D printing.开发一种定量方法来评估用于熔融沉积建模 3D 打印的细丝的可打印性。
Int J Pharm. 2020 Oct 15;588:119760. doi: 10.1016/j.ijpharm.2020.119760. Epub 2020 Aug 12.
4
Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling.基于药用级聚合物的热熔挤出长丝,用于通过熔融沉积建模进行3D打印。
Int J Pharm. 2016 Jul 25;509(1-2):255-263. doi: 10.1016/j.ijpharm.2016.05.036. Epub 2016 May 20.
5
3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.3D 打印制药口服固体制剂的熔融沉积法:使用增塑 HPMCAS 提高可印刷性。
Int J Pharm. 2022 Mar 25;616:121553. doi: 10.1016/j.ijpharm.2022.121553. Epub 2022 Feb 5.
6
The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.药物聚合物共混物在熔融沉积成型(FDM)3D 技术中的适用性:材料考虑因素——可印刷性——工艺调节,对体外释放、稳定性和降解有连续影响。
Eur J Pharm Sci. 2019 Mar 1;129:110-123. doi: 10.1016/j.ejps.2018.12.019. Epub 2019 Jan 2.
7
Investigation on hot melt extrusion and prediction on 3D printability of pharmaceutical grade polymers.药用级聚合物的热熔挤出研究及3D打印适性预测
Int J Pharm. 2021 Jul 15;604:120755. doi: 10.1016/j.ijpharm.2021.120755. Epub 2021 May 28.
8
Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.药物辅料适用于熔融沉积成型3D打印以制造患者定制的速释片剂。
Int J Pharm. 2016 Nov 20;513(1-2):659-668. doi: 10.1016/j.ijpharm.2016.09.050. Epub 2016 Sep 15.
9
Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.释放调节剂在熔融沉积成型(FDM)3D 打印片剂中调节药物释放的作用。
Int J Pharm. 2021 Mar 15;597:120315. doi: 10.1016/j.ijpharm.2021.120315. Epub 2021 Feb 1.
10
Brittle polymers in Fused Deposition Modeling: An improved feeding approach to enable the printing of highly drug loaded filament.熔融沉积成型中的脆性聚合物:一种改进的进料方法,可实现高载药量丝材的打印。
Int J Pharm. 2021 Mar 15;597:120216. doi: 10.1016/j.ijpharm.2021.120216. Epub 2021 Jan 22.

引用本文的文献

1
Soluplus-Based Pharmaceutical Formulations: Recent Advances in Drug Delivery and Biomedical Applications.基于Soluplus的药物制剂:药物递送与生物医学应用的最新进展
Int J Mol Sci. 2025 Feb 11;26(4):1499. doi: 10.3390/ijms26041499.
2
An Additive Manufacturing MicroFactory: Overcoming Brittle Material Failure and Improving Product Performance through Tablet Micro-Structure Control for an Immediate Release Dose Form.增材制造微型工厂:通过控制速释剂型的片剂微观结构来克服脆性材料失效并提高产品性能。
Polymers (Basel). 2024 Sep 11;16(18):2566. doi: 10.3390/polym16182566.
3
Understanding the Interaction of Thermal, Rheological, and Mechanical Parameters Critical for the Processability of Polyvinyl Alcohol-Based Systems during Hot Melt Extrusion.
理解热熔挤出过程中对基于聚乙烯醇的体系加工性能至关重要的热、流变和机械参数之间的相互作用。
Pharmaceutics. 2024 Mar 28;16(4):472. doi: 10.3390/pharmaceutics16040472.
4
Customizable Three-Dimensional Printed Earring Tap for Treating Affections Caused by Aesthetic Perforations.用于治疗美学穿孔所致病症的可定制三维打印耳环塞
Pharmaceutics. 2024 Jan 5;16(1):77. doi: 10.3390/pharmaceutics16010077.
5
Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.快速溶解的熔融沉积成型3D打印片剂开发中的挑战、现状及新兴策略:综述与评论
ADMET DMPK. 2023 Jan 1;11(1):33-55. doi: 10.5599/admet.1622. eCollection 2023.
6
Processability of mesoporous materials in fused deposition modeling for drug delivery of a model thermolabile drug.介孔材料在熔融沉积成型中用于一种模型热敏药物给药的可加工性。
Int J Pharm X. 2022 Dec 17;5:100149. doi: 10.1016/j.ijpx.2022.100149. eCollection 2023 Dec.
7
Direct Granule Feeding of Thermal Droplet Deposition 3D Printing of Porous Pharmaceutical Solid Dosage Forms Free of Plasticisers.直接颗粒进料的热液滴沉积 3D 打印无增塑剂的多孔药物固体剂型。
Pharm Res. 2022 Mar;39(3):599-610. doi: 10.1007/s11095-022-03198-x. Epub 2022 Feb 22.
8
3D Printed Buccal Films for Prolonged-Release of Propranolol Hydrochloride: Development, Characterization and Bioavailability Prediction.用于盐酸普萘洛尔缓释的3D打印口腔薄膜:研制、表征及生物利用度预测
Pharmaceutics. 2021 Dec 13;13(12):2143. doi: 10.3390/pharmaceutics13122143.
9
Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets.SLA打印微丸中与亲水性辅料无关的药物释放
Pharmaceutics. 2021 Oct 17;13(10):1717. doi: 10.3390/pharmaceutics13101717.
10
Development of a 3D-Printed Dosing Platform to Aid in Zolpidem Withdrawal Therapy.开发用于辅助唑吡坦戒断治疗的3D打印给药平台。
Pharmaceutics. 2021 Oct 14;13(10):1684. doi: 10.3390/pharmaceutics13101684.